Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP740391.RAlkQ4irILG8V6HtkieuVOEFFFmXu9H_4bdtG41I_46qU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP740391.RAlkQ4irILG8V6HtkieuVOEFFFmXu9H_4bdtG41I_46qU130_assertion type Assertion NP740391.RAlkQ4irILG8V6HtkieuVOEFFFmXu9H_4bdtG41I_46qU130_head.
- NP740391.RAlkQ4irILG8V6HtkieuVOEFFFmXu9H_4bdtG41I_46qU130_assertion description "[We describe the antitumor activity of MP-412 (AV-412), a dual EGFR/ErbB2 kinase inhibitor, against three lung cancer models with EGFR and ErbB2 mutations and also against various human xenografts with overexpression of these receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP740391.RAlkQ4irILG8V6HtkieuVOEFFFmXu9H_4bdtG41I_46qU130_provenance.
- NP740391.RAlkQ4irILG8V6HtkieuVOEFFFmXu9H_4bdtG41I_46qU130_assertion evidence source_evidence_literature NP740391.RAlkQ4irILG8V6HtkieuVOEFFFmXu9H_4bdtG41I_46qU130_provenance.
- NP740391.RAlkQ4irILG8V6HtkieuVOEFFFmXu9H_4bdtG41I_46qU130_assertion SIO_000772 19459856 NP740391.RAlkQ4irILG8V6HtkieuVOEFFFmXu9H_4bdtG41I_46qU130_provenance.
- NP740391.RAlkQ4irILG8V6HtkieuVOEFFFmXu9H_4bdtG41I_46qU130_assertion wasDerivedFrom befree-2016 NP740391.RAlkQ4irILG8V6HtkieuVOEFFFmXu9H_4bdtG41I_46qU130_provenance.
- NP740391.RAlkQ4irILG8V6HtkieuVOEFFFmXu9H_4bdtG41I_46qU130_assertion wasGeneratedBy ECO_0000203 NP740391.RAlkQ4irILG8V6HtkieuVOEFFFmXu9H_4bdtG41I_46qU130_provenance.